Status:
TERMINATED
Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B)
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Vitamin K Status
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall purpose of this study is to determine how variation in the CYP4F2 gene modulates the synthesis of vitamin K-dependent clotting factors. We propose that the CYP4F2\*3 gene variant increases...
Detailed Description
The investigators will study the effect of vitamin K supplementation on two biomarkers of hepatic vitamin K concentration in groups with defined CYP4F2\*3 genotype. Specifically, the investigators wil...
Eligibility Criteria
Inclusion
- Participants will be males or females 18 years and older.
- Participants must read and understand English.
- Participants must be able to provide informed consent.
- Women not currently pregnant or lactating.
Exclusion
- Participants less than 18 years of age.
- Participants unable to read and understand English.
- Participants unable to provide informed consent.
- Women who are pregnant or lactating.
Key Trial Info
Start Date :
August 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04450212
Start Date
August 25 2017
End Date
July 31 2023
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195